Cite
MLA Citation
S Novello et al.. “Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study.” Annals of oncology, vol. 29, 2018, pp. 1409–1416. http://access.bl.uk/ark:/81055/vdc_100095324268.0x00003b